Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 424

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 424
---
 to all intents and purposes as we might or could do in person, hereby ratifying and confirming all facts and things that said attorney-in-fact and agent, or his substitute may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement on Form F-1 has been signed by the following persons in the capacities and on the date indicated.

| Name and Signature        
 /s/ Stephen Stamp         |     | Title(s)                                                                                  
 Chief Executive Officer, Director,                                                        |     | Date             
 January 17, 2025 |
|:--------------------------|:----|:------------------------------------------------------------------------------------------|:----|:-----------------|
| Stephen Stamp             |     | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |                  |
| /s/ Stephen Parker        |     | Non-Executive Chairman of the Board                                                       |     | January 17, 2025 |
| Stephen Parker            |     |                                                                                           |     |                  |
| /s/ Simon Turton, Ph.D.   |     | Senior Independent Non-Executive Director                                                 |     | January 17, 2025 |
| Simon Turton, Ph.D.       |     |                                                                                           |     |                  |
| /s/ Sijmen de Vries, M.D. |     | Non-Executive Director                                                                    |     | January 17, 2025 |
| Sijmen de Vries, M.D.     |     |                                                                                           |     |                  |
| /s/ Ann Merchant          |     | Non-Executive Director                                                                    |     | January 17, 2025 |
| Ann Merchant              |     |                                                                                           |     |                  |

| II-5 |

<div align='center'>AUTHORIZED REPRESENTATIVE</div>

Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement on Form F-1 has been signed by the undersigned on this 17th day of January, 2025.

| By:    | /s/ Donald J. Puglisi                          |
| Name:  | Donald J. Puglisi                              |
| Title: | Authorized Representative in the United States |

| II-6 |

<div align='center'>Exhibit Index</div>

| Exhibit 
 Number  
 3.1     | Title                                                                                                                                                                                                                                                                                                                                                                                         
 Articles of Association of Biodexa Pharmaceuticals PLC, adopted on